Nika Pharmaceuticals, Inc. (NIKA) Presents Its Business Strategy Nika Pharmaceuticals, Inc. (NIKA) introduces its business strategy that should generate a net profit of more than 1 billion USD by the end of 2025.

Nika Pharmaceuticals, Inc. (NIKA) Acquires a Two Million USD Production Building Nika Pharmaceuticals, Inc. (NIKA) acquired production building and land valued at $2,045,209 and signed a supply agreement for vial production line.

Nika Pharmaceuticals, Inc. (Nika) Acquires a Two Million USD Production Building Nika Pharmaceuticals, Inc. (NIKA) acquired production building and land valued at $2,045,209 and signed a supply agreement for vial production line.

Nika Pharmaceuticals, Inc. (NKPH) Purchased the Technologies for Three Drugs in Tablet Form and One Dietary Supplement Nika Pharmaceuticals, Inc. (NKPH) announces the purchase of technologies for production of three generic drugs in tablet form and one dietary supplement.

Nika Pharmaceuticals, Inc. (NKPH) Merges With Nika Biotechnology, Inc. Nika Pharmaceuticals, Inc. (OTCMKTS: NKPH) announces its merger with Nika BioTechnology, Inc., effective as of March 1, 2024.